Takeda · 2 hours ago
2026 Summer Internship Program: Global Structural Biology Intern
Takeda is a pharmaceutical company that specializes in drug discovery and development. The Global Structural Biology intern will work with experts across various disciplines to understand the impact of structural biology on drug discovery and contribute to protein production and biophysical experiments.
BiotechnologyHealth CareManufacturingMedicalPharmaceutical
Responsibilities
Execute protein production activities (expression and purification of protein targets, complex formation, etc)
Run biophysical experiments including, but not limited to SPR, DLS, DSF, etc
Set up crystallization trays using crystallization workcell and prepare crystals for data collection
Prepare grid samples for cryoEM data collection
Qualification
Required
Must be a pursuing a Bachelors, Masters, or Ph.D degree
A foundational knowledge of proteins and protein structure
This position requires full-time commitment, necessitating five days of on-site work at the Cambridge site
Demonstrated ability to work effectively as a collaborative team member
Comfortable working in a laboratory environment and including work in biosafety hoods
Willingness to wear personal protective equipment (PPE) appropriate for BL2 safety levels, such as safety glasses, gloves, closed toe shoes, etc
Must be authorized to work in the U.S. on a permanent basis without requiring sponsorship
Must be currently enrolled in a degree program graduating December 2026 or later
The intern must be able to commit to one of these time frames
Able to work full time 40 hours a week during internship dates
Benefits
Paid sick time
Civic Duty paid time off
Participation at company volunteer events
Participation at company sponsored special events
Access to on-site fitness center (where available)
Commuter Benefit To offset your work-commute expenses, Takeda provides U.S. employees with a fixed monthly subsidy to be used for either public transportation (transit) or parking.
Company
Takeda
Takeda is a biopharmaceutical company that researches and develops pharmaceutical drugs.
Funding
Current Stage
Public CompanyTotal Funding
$2.46B2025-06-27Post Ipo Debt· $2.4B
2016-09-01Grant· $19.8M
2016-05-08Grant· $38M
Leadership Team
Recent News
2025-12-30
Company data provided by crunchbase